The International Trade Commission has instituted the following investigations to determine whether imports of the products indicated are violating Section 337 of the 1930 Tariff Act.
- patent and trademark infringement investigation 337-TA-1007 of personal transporters, components thereof, and packaging and manuals therefor (self-balancing electric vehicles for carrying a person; complainants Segway Inc., DEKA Products Limited Partnership and Ninebot (Tianjin) Technology Co. Ltd.; respondents located in the U.S.)
- patent, copyright, trademark and trade dress rights infringement investigation 337-TA-1008 of carbon spine board, cervical collar, CPR masks and various medical training manikin devices, and trademarks, copyrights of product catalogues, product inserts and components thereof (complainants Laerdal Medical Corp. and Laerdal Medical AS; respondents located in China and the U.S.)
- patent infringement investigation 337-TA-1009 of inflatable products with tensioning structures and processes for making same (products such as air mattresses with internal tensioning structures that help maintain the intended shape of the products; complainants Intex Recreation Corp. and Intex Marketing Ltd.; complainants located in China, Hong Kong and the U.S.)
- patent infringement investigation 337-TA-1010 of semiconductor devices, semiconductor device packages and products containing same (including mobile devices, set-top boxes, gateways, modems, routers, Ethernet switches, network routing equipment, and infrastructure equipment for telecommunications, cable, networking, and cloud and enterprise systems; complainants Tessera Technologies Inc., Tessera Inc. and Invensas Corporation; respondents located in Singapore, England, Taiwan, France and the U.S.)
In each case the complainants request that after the investigation the ITC issue an exclusion order, which would direct U.S. Customs and Border Protection to prohibit the entry of infringing products into the U.S., and/or cease and desist orders, which would require the named respondents to cease actions that violate Section 337, including selling infringing imported articles out of U.S. inventory.